{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:23:15Z","timestamp":1794572595048,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/24\/130011, RE\/18\/1\/34212"],"award-info":[{"award-number":["RE\/24\/130011, RE\/18\/1\/34212"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/24\/130011, RE\/18\/1\/34212"],"award-info":[{"award-number":["RE\/24\/130011, RE\/18\/1\/34212"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/10\/001\/27642"],"award-info":[{"award-number":["CH\/10\/001\/27642"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/ICRF\/24\/26114, FS\/CRTF\/24\/24605"],"award-info":[{"award-number":["FS\/ICRF\/24\/26114, FS\/CRTF\/24\/24605"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["IA\/F\/23\/275046, PG\/23\/11508"],"award-info":[{"award-number":["IA\/F\/23\/275046, PG\/23\/11508"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000374","name":"British Medical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000327","name":"Heart Research UK","doi-asserted-by":"publisher","award":["RG2699\/21\/23"],"award-info":[{"award-number":["RG2699\/21\/23"]}],"id":[{"id":"10.13039\/501100000327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000327","name":"Heart Research UK","doi-asserted-by":"publisher","award":["RG2699\/21\/23"],"award-info":[{"award-number":["RG2699\/21\/23"]}],"id":[{"id":"10.13039\/501100000327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005370","name":"Gates Cambridge Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005370","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH Oxford-Cambridge Scholars Program"},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["ZIA\/hl006223"],"award-info":[{"award-number":["ZIA\/hl006223"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220268\/Z\/20\/Z"],"award-info":[{"award-number":["220268\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["BCVD\/20CVD03"],"award-info":[{"award-number":["BCVD\/20CVD03"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Targeting inflammation in atherosclerotic cardiovascular disease remains a major unmet need. Low-dose interleukin-2 (IL-2\n                    <jats:sub>LD<\/jats:sub>\n                    ) selectively increases regulatory T (T\n                    <jats:sub>reg<\/jats:sub>\n                    ) cell numbers in patients with coronary artery disease. Here we combine single-cell transcriptomics and T cell receptor analyses and show that IL-2\n                    <jats:sub>LD<\/jats:sub>\n                    clonally expands effector T\n                    <jats:sub>reg<\/jats:sub>\n                    cells in patients with acute coronary syndromes. The clonally expanded T\n                    <jats:sub>reg<\/jats:sub>\n                    cells upregulate key immunosuppressive and metabolic pathways and show an increased number of predicted ligand\u2013receptor interactions. These T\n                    <jats:sub>reg<\/jats:sub>\n                    cells also display similar predicted antigen specificities, which cluster with published sequences specific to atherosclerotic cardiovascular disease. By tracking the T cell receptors of single cells over time, we identify an inflammatory polarization of the T cell compartment after myocardial infarction, which is restrained by IL-2\n                    <jats:sub>LD<\/jats:sub>\n                    . We identify BACH2 as a repressor of the T\n                    <jats:sub>reg<\/jats:sub>\n                    effector program. However, BACH2-mediated regulation is bypassed with IL-2\n                    <jats:sub>LD<\/jats:sub>\n                    . Overall, these results lend insight into the IL-2-driven clonal expansion program in human T\n                    <jats:sub>reg<\/jats:sub>\n                    cells, with important therapeutic implications for patients with cardiovascular and other immune-mediated diseases.\n                  <\/jats:p>","DOI":"10.1038\/s44161-025-00652-y","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:02:19Z","timestamp":1748926939000},"page":"727-739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Low-dose interleukin-2 induces clonal expansion of BACH2-repressed effector regulatory T cells following acute coronary syndrome"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9027-6339","authenticated-orcid":false,"given":"A. G.","family":"Case","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-8988","authenticated-orcid":false,"given":"J. W.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. T. W.","family":"Charlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9922-2815","authenticated-orcid":false,"given":"X.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6735-6808","authenticated-orcid":false,"given":"Z. K.","family":"Tuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sriranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cheriyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Clatworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-7878","authenticated-orcid":false,"given":"Z.","family":"Mallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0202-5255","authenticated-orcid":false,"given":"T. X.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"652_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby, P., Ridker, P. M., Hansson, G. K. & Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 54, 2129\u20132138 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"652_CR2","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1161\/ATVBAHA.116.307993","volume":"36","author":"Y-C Chen","year":"2016","unstructured":"Chen, Y.-C., Huang, A. L., Kyaw, T. S., Bobik, A. & Peter, K. Atherosclerotic plaque rupture: identifying the straw that breaks the camel\u2019s back. Arterioscler. Thromb. Vasc. Biol. 36, e63\u2013e72 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo, L., Rocha-Resende, C., Prabhu, S. D. & Mann, D. L. Reappraising the role of inflammation in heart failure. Nat. Rev. Cardiol. 17, 269\u2013285 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"652_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405922","author":"SS Jolly","year":"2024","unstructured":"Jolly, S. S. et al. Colchicine in acute myocardial infarction. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2405922 (2024).","journal-title":"N. Engl. J. Med."},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/ATVBAHA.119.312287","volume":"40","author":"TX Zhao","year":"2020","unstructured":"Zhao, T. X., Newland, S. A. & Mallat, Z. Interleukin-2 therapy in cardiovascular disease: the potential to regulate innate and adaptive immunity. Arterioscler. Thromb. Vasc. Biol. 40, 853\u2013864 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"652_CR6","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1161\/ATVBAHA.112.251579","volume":"32","author":"M Wigren","year":"2012","unstructured":"Wigren, M. et al. Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler. Thromb. Vasc. Biol. 32, 2000\u20132004 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"652_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri3823","volume":"15","author":"D Klatzmann","year":"2015","unstructured":"Klatzmann, D. & Abbas, A. K. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15, 283\u2013294 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"652_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ni.3540","volume":"17","author":"T Chinen","year":"2016","unstructured":"Chinen, T. et al. An essential role for the IL-2 receptor in Treg cell function. Nat. Immunol. 17, 1322\u20131333 (2016).","journal-title":"Nat. Immunol."},{"key":"652_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nm1343","volume":"12","author":"H Ait-Oufella","year":"2006","unstructured":"Ait-Oufella, H. et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178\u2013180 (2006).","journal-title":"Nat. Med."},{"key":"652_CR10","doi-asserted-by":"publisher","first-page":"EVIDoa2100009","DOI":"10.1056\/EVIDoa2100009","volume":"1","author":"TX Zhao","year":"2022","unstructured":"Zhao, T. X. et al. Regulatory T-cell response to low-dose interleukin-2 in ischemic heart disease. NEJM Evid. 1, EVIDoa2100009 (2022).","journal-title":"NEJM Evid."},{"key":"652_CR11","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.immuni.2024.07.016","volume":"57","author":"ME Raeber","year":"2024","unstructured":"Raeber, M. E. et al. Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics. Immunity 57, 2232\u20132250.e10 (2024).","journal-title":"Immunity"},{"key":"652_CR12","doi-asserted-by":"publisher","first-page":"47ra64","DOI":"10.1126\/scitranslmed.3001442","volume":"2","author":"HS Robins","year":"2010","unstructured":"Robins, H. S. et al. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci. Transl. Med. 2, 47ra64 (2010).","journal-title":"Sci. Transl. Med."},{"key":"652_CR13","doi-asserted-by":"crossref","unstructured":"Das, J. & Jayaprakash, C. (eds). Systems Immunology: An Introduction to Modeling Methods for Scientists (CRC Press, 2019).","DOI":"10.1201\/9781315119847"},{"key":"652_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","volume":"186","author":"S-B Ong","year":"2018","unstructured":"Ong, S.-B. et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol. Ther. 186, 73\u201387 (2018).","journal-title":"Pharmacol. Ther."},{"key":"652_CR15","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41592-024-02303-9","volume":"21","author":"P Weiler","year":"2024","unstructured":"Weiler, P., Lange, M., Klein, M., Pe\u2019er, D. & Theis, F. CellRank 2: unified fate mapping in multiview single-cell data. Nat. Methods 21, 1196\u20131205 (2024).","journal-title":"Nat. Methods"},{"key":"652_CR16","doi-asserted-by":"publisher","first-page":"664514","DOI":"10.3389\/fimmu.2021.664514","volume":"12","author":"I Springer","year":"2021","unstructured":"Springer, I., Tickotsky, N. & Louzoun, Y. Contribution of T cell receptor alpha and beta CDR3, MHC typing, V and J genes to peptide binding prediction. Front. Immunol. 12, 664514 (2021).","journal-title":"Front. Immunol."},{"key":"652_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194\u20131202 (2020).","journal-title":"Nat. Biotechnol."},{"key":"652_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41587-021-00989-2","volume":"40","author":"SA Schattgen","year":"2022","unstructured":"Schattgen, S. A. et al. Integrating T cell receptor sequences and transcriptional profiles by clonotype neighbor graph analysis (CoNGA). Nat. Biotechnol. 40, 54\u201363 (2022).","journal-title":"Nat. Biotechnol."},{"key":"652_CR19","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1093\/bioinformatics\/btx286","volume":"33","author":"N Tickotsky","year":"2017","unstructured":"Tickotsky, N., Sagiv, T., Prilusky, J., Shifrut, E. & Friedman, N. McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences. Bioinformatics 33, 2924\u20132929 (2017).","journal-title":"Bioinformatics"},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/CIRCRESAHA.121.320090","volume":"130","author":"RR Chowdhury","year":"2022","unstructured":"Chowdhury, R. R. et al. Human coronary plaque T cells are clonal and cross-react to virus and self. Circ. Res. 130, 1510\u20131530 (2022).","journal-title":"Circ. Res."},{"key":"652_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s44161-022-00063-3","volume":"1","author":"R Saigusa","year":"2022","unstructured":"Saigusa, R. et al. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Nat. Cardiovasc. Res. 1, 462\u2013475 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"652_CR22","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1161\/HYPERTENSIONAHA.123.21112","volume":"80","author":"X Ma","year":"2023","unstructured":"Ma, X. et al. Reduced diversities and clonally expanded sequences of T-cell receptors in patients with essential hypertension and subclinical carotid atherosclerosis. Hypertension 80, 2318\u20132329 (2023).","journal-title":"Hypertension"},{"key":"652_CR23","doi-asserted-by":"publisher","first-page":"1302031","DOI":"10.3389\/fimmu.2024.1302031","volume":"15","author":"P Roy","year":"2024","unstructured":"Roy, P., Suthahar, S. S. A., Makings, J. & Ley, K. Identification of apolipoprotein B-reactive CDR3 motifs allows tracking of atherosclerosis-related memory CD4+ T cells in multiple donors. Front. Immunol. 15, 1302031 (2024).","journal-title":"Front. Immunol."},{"key":"652_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1788-4","volume":"17","author":"D Li","year":"2019","unstructured":"Li, D. et al. Peripheral T cell receptor beta immune repertoire is promptly reconstituted after acute myocardial infarction. J. Transl. Med. 17, 40 (2019).","journal-title":"J. Transl. Med."},{"key":"652_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1768-8","volume":"17","author":"Z Zhong","year":"2019","unstructured":"Zhong, Z., Wu, H., Zhang, Q., Zhong, W. & Zhao, P. Characteristics of T cell receptor repertoires of patients with acute myocardial infarction through high-throughput sequencing. J. Transl. Med. 17, 21 (2019).","journal-title":"J. Transl. Med."},{"key":"652_CR26","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1093\/eurheartj\/ehz516","volume":"40","author":"T-T Tang","year":"2019","unstructured":"Tang, T.-T. et al. Pathologic T-cell response in ischaemic failing hearts elucidated by T-cell receptor sequencing and phenotypic characterization. Eur. Heart J. 40, 3924\u20133933 (2019).","journal-title":"Eur. Heart J."},{"key":"652_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2022.09.001","volume":"173","author":"N Hapke","year":"2022","unstructured":"Hapke, N. et al. Identification of a novel cardiac epitope triggering T-cell responses in patients with myocardial infarction. J. Mol. Cell. Cardiol. 173, 25\u201329 (2022).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"652_CR28","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1172\/JCI95713","volume":"128","author":"C McDonald-Hyman","year":"2018","unstructured":"McDonald-Hyman, C. et al. The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease. J. Clin. Invest. 128, 4604\u20134621 (2018).","journal-title":"J. Clin. Invest."},{"key":"652_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159\u2013162 (2020).","journal-title":"Nat. Methods"},{"key":"652_CR30","doi-asserted-by":"publisher","unstructured":"Browaeys, R. et al. MultiNicheNet: a flexible framework for differential cell\u2013cell communication analysis from multi-sample multi-condition single-cell transcriptomics data. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.06.13.544751 (2023).","DOI":"10.1101\/2023.06.13.544751"},{"key":"652_CR31","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.it.2015.10.007","volume":"36","author":"D Amsen","year":"2015","unstructured":"Amsen, D., Helbig, C. & Backer, R. A. Notch in T cell differentiation: all things considered. Trends Immunol. 36, 802\u2013814 (2015).","journal-title":"Trends Immunol."},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/jid.2008.323","volume":"129","author":"U Anderegg","year":"2009","unstructured":"Anderegg, U. et al. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells. J. Invest. Dermatol. 129, 1471\u20131482 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"652_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00430-020-00677-z","volume":"209","author":"VE Dunlock","year":"2020","unstructured":"Dunlock, V. E. Tetraspanin CD53: an overlooked regulator of immune cell function. Med. Microbiol. Immunol. 209, 545\u2013552 (2020).","journal-title":"Med. Microbiol. Immunol."},{"key":"652_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1158\/2326-6066.CIR-14-0150","volume":"3","author":"T Kouo","year":"2015","unstructured":"Kouo, T. et al. Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells. Cancer Immunol. Res. 3, 412\u2013423 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"652_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2023.02.007","volume":"156","author":"D White","year":"2023","unstructured":"White, D. et al. Programmed Cell Death-1 (PD-1) anchoring to the GPI-linked co-receptor CD48 reveals a novel mechanism to modulate PD-1-dependent inhibition of human T cells. Mol. Immunol. 156, 31\u201338 (2023).","journal-title":"Mol. Immunol."},{"key":"652_CR36","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"652_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature12199","volume":"498","author":"R Roychoudhuri","year":"2013","unstructured":"Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis. Nature 498, 506\u2013510 (2013).","journal-title":"Nature"},{"key":"652_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14112-2","volume":"11","author":"T Sidwell","year":"2020","unstructured":"Sidwell, T. et al. Attenuation of TCR-induced transcription by Bach2 controls regulatory T cell differentiation and homeostasis. Nat. Commun. 11, 252 (2020).","journal-title":"Nat. Commun."},{"key":"652_CR39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190711","volume":"217","author":"FM Grant","year":"2020","unstructured":"Grant, F. M. et al. BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression. J. Exp. Med. 217, e20190711 (2020).","journal-title":"J. Exp. Med."},{"key":"652_CR40","doi-asserted-by":"publisher","first-page":"109096","DOI":"10.1016\/j.celrep.2021.109096","volume":"35","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Bach2 attenuates IL-2R signaling to control Treg homeostasis and Tfr development. Cell Rep. 35, 109096 (2021).","journal-title":"Cell Rep."},{"key":"652_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/cei\/uxac105","volume":"211","author":"F Harris","year":"2023","unstructured":"Harris, F., Berdugo, Y. A. & Tree, T. IL-2-based approaches to Treg enhancement. Clin. Exp. Immunol. 211, 149\u2013163 (2023).","journal-title":"Clin. Exp. Immunol."},{"key":"652_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/ATVBAHA.119.312287","volume":"40","author":"TX Zhao","year":"2020","unstructured":"Zhao, T. X., Newland, S. A. & Mallat, Z. 2019 ATVB Plenary Lecture: Interleukin-2 therapy in cardiovascular disease: the potential to regulate innate and adaptive immunity. Arterioscler. Thromb. Vasc. Biol. 40, 853\u2013864 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"652_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062602","volume":"12","author":"R Sriranjan","year":"2022","unstructured":"Sriranjan, R. et al. Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial. BMJ Open 12, e062602 (2022).","journal-title":"BMJ Open"},{"key":"652_CR44","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1172\/JCI123859","volume":"129","author":"M Rieckmann","year":"2019","unstructured":"Rieckmann, M. et al. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J. Clin. Invest. 129, 4922\u20134936 (2019).","journal-title":"J. Clin. Invest."},{"key":"652_CR45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCULATIONAHA.118.036065","volume":"139","author":"SS Bansal","year":"2019","unstructured":"Bansal, S. S. et al. Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy. Circulation 139, 206\u2013221 (2019).","journal-title":"Circulation"},{"key":"652_CR46","doi-asserted-by":"publisher","first-page":"e97011","DOI":"10.1371\/journal.pone.0097011","volume":"9","author":"W Tinago","year":"2014","unstructured":"Tinago, W. et al. Clinical, immunological and treatment-related factors associated with normalised CD4+\/CD8+ T-cell ratio: effect of na\u00efve and memory T-cell subsets. PLoS ONE 9, e97011 (2014).","journal-title":"PLoS ONE"},{"key":"652_CR47","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"652_CR48","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.123.064974","volume":"149","author":"S Prapiadou","year":"2024","unstructured":"Prapiadou, S. et al. Proteogenomic data integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis. Circulation 149, 669\u2013683 (2024).","journal-title":"Circulation"},{"key":"652_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby, P. et al. Atherosclerosis. Nat. Rev. Dis. Primers 5, 56 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"652_CR50","doi-asserted-by":"publisher","first-page":"4396368","DOI":"10.1155\/2016\/4396368","volume":"2016","author":"R Altara","year":"2016","unstructured":"Altara, R., Mallat, Z., Booz, G. W. & Zouein, F. A. The CXCL10\/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart. J. Immunol. Res. 2016, 4396368 (2016).","journal-title":"J. Immunol. Res."},{"key":"652_CR51","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2017.10.017","volume":"47","author":"M Kishore","year":"2017","unstructured":"Kishore, M. et al. Regulatory T cell migration is dependent on glucokinase-mediated glycolysis. Immunity 47, 875\u2013889.e10 (2017).","journal-title":"Immunity"},{"key":"652_CR52","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A. et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282\u20131293.e7 (2017).","journal-title":"Cell Metab."},{"key":"652_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89160","volume":"2","author":"D Howie","year":"2017","unstructured":"Howie, D. et al. Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. JCI Insight 2, e89160 (2017).","journal-title":"JCI Insight"},{"key":"652_CR54","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.4049\/jimmunol.1800311","volume":"201","author":"B Priyadharshini","year":"2018","unstructured":"Priyadharshini, B. et al. Cutting edge: TGF-\u03b2 and phosphatidylinositol 3-kinase signals modulate distinct metabolism of regulatory T cell subsets. J. Immunol. 201, 2215\u20132219 (2018).","journal-title":"J. Immunol."},{"key":"652_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22975-7","volume":"12","author":"G Mijnheer","year":"2021","unstructured":"Mijnheer, G. et al. Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation. Nat. Commun. 12, 2710 (2021).","journal-title":"Nat. Commun."},{"key":"652_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s44161-022-00208-4","volume":"2","author":"MAC Depuydt","year":"2023","unstructured":"Depuydt, M. A. C. et al. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells. Nat. Cardiovasc. Res. 2, 112\u2013125 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"652_CR57","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/ni.2084","volume":"12","author":"M Beyer","year":"2011","unstructured":"Beyer, M. et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat. Immunol. 12, 898\u2013907 (2011).","journal-title":"Nat. Immunol."},{"key":"652_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nature14154","volume":"520","author":"G Vahedi","year":"2015","unstructured":"Vahedi, G. et al. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 520, 558\u2013562 (2015).","journal-title":"Nature"},{"key":"652_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ni.3646","volume":"18","author":"Y Kitagawa","year":"2017","unstructured":"Kitagawa, Y. et al. Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. Nat. Immunol. 18, 173\u2013183 (2017).","journal-title":"Nat. Immunol."},{"key":"652_CR60","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.20182010","volume":"216","author":"S Xing","year":"2019","unstructured":"Xing, S. et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J. Exp. Med. 216, 847\u2013866 (2019).","journal-title":"J. Exp. Med."},{"key":"652_CR61","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1016\/j.celrep.2019.05.061","volume":"27","author":"B-H Yang","year":"2019","unstructured":"Yang, B.-H. et al. TCF1 and LEF1 control Treg competitive survival and Tfr development to prevent autoimmune diseases. Cell Rep. 27, 3629\u20133645.e6 (2019).","journal-title":"Cell Rep."},{"key":"652_CR62","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1371\/journal.pone.0000779","volume":"2","author":"OJ de Boer","year":"2007","unstructured":"de Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M. & van der Wal, A. C. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2, e779 (2007).","journal-title":"PLoS ONE"},{"key":"652_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37424-w","volume":"14","author":"A Inaba","year":"2023","unstructured":"Inaba, A. et al. Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells. Nat. Commun. 14, 2071 (2023).","journal-title":"Nat. Commun."},{"key":"652_CR64","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41592-021-01171-x","volume":"18","author":"PV Kharchenko","year":"2021","unstructured":"Kharchenko, P. V. The triumphs and limitations of computational methods for scRNA-seq. Nat. Methods 18, 723\u2013732 (2021).","journal-title":"Nat. Methods"}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00652-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00652-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00652-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:02:43Z","timestamp":1750096963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00652-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1038\/s44161-025-00652-y","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}